FKBP4P6

Across TCGA pan-cancer cohorts, FKBP4P6 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FKBP4P6 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher FKBP4P6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FKBP4P6 expression acts as an unfavorable survival marker, although some lineages such as LUSC and SKCM show a favorable association.

CHOL, ACC, and LIHC are the cancer types where FKBP4P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	DFS	Tertile	III,IV	0.031	0.505	.003	72	view →
ACC	OS	Quartile	IV	0.260	0.702	.004	71	view →
LIHC	DFS	Quartile	All	0.297	0.478	.002	48	view →
LUSC	OS	Median	All	0.822	0.604	.001	46	view →
KIRP	DFS	Tertile	All	0.407	0.716	<.001	41	view →
KICH	DFS	Quartile	All	0.246	0.944	<.001	38	view →
SKCM	OS	Median	All	0.938	0.800	.002	26	view →
READ	DFS	Quartile	All	0.841	0.445	.018	21	view →
LUAD	DFS	Median	IV	0.666	0.978	.015	18	view →
DLBC	DFS	Tertile	IV	0.120	0.827	.025	9	view →
STAD	OS	Tertile	II,III,IV	0.426	0.687	.038	6	view →
GBM	DFS	Quartile	All	0.282	0.166	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

FKBP4P6–CHOL (DFS)

Open the CHOL breakdown →